Hsieh JT - Search Results

1

Karam JA, Mason RP, Koeneman KS, Antich PP, Benaim EA, Hsieh JT. Karam JA, et al. Among authors: hsieh jt. J Cell Biochem. 2003 Oct 15;90(3):473-83. doi: 10.1002/jcb.10636. J Cell Biochem. 2003. PMID: 14523981 Review.

2

The application of epigenetic modifiers on the treatment of prostate and bladder cancer.

Zhang Z, Karam J, Frenkel E, Sagalowsky A, Hsieh JT. Zhang Z, et al. Among authors: hsieh jt. Urol Oncol. 2006 Mar-Apr;24(2):152-60. doi: 10.1016/j.urolonc.2005.11.004. Urol Oncol. 2006. PMID: 16520279 Review.

3

Cloning of mouse Dab2ip gene, a novel member of the RasGTPase-activating protein family and characterization of its regulatory region in prostate.

Chen H, Karam JA, Schultz R, Zhang Z, Duncan C, Hsieh JT. Chen H, et al. Among authors: hsieh jt. DNA Cell Biol. 2006 Apr;25(4):232-45. doi: 10.1089/dna.2006.25.232. DNA Cell Biol. 2006. PMID: 16629596

4

Conditionally replicating adenovirus-mediated gene therapy in bladder cancer: an orthotopic in vivo model.

Melquist JJ, Kacka M, Li Y, Malaeb BS, Elmore J, Baseman AG, Hsieh JT, Koeneman KS. Melquist JJ, et al. Among authors: hsieh jt. Urol Oncol. 2006 Jul-Aug;24(4):362-71. doi: 10.1016/j.urolonc.2005.11.028. Urol Oncol. 2006. PMID: 16818192

5

The use of histone deacetylase inhibitor FK228 and DNA hypomethylation agent 5-azacytidine in human bladder cancer therapy.

Karam JA, Fan J, Stanfield J, Richer E, Benaim EA, Frenkel E, Antich P, Sagalowsky AI, Mason RP, Hsieh JT. Karam JA, et al. Among authors: hsieh jt. Int J Cancer. 2007 Apr 15;120(8):1795-802. doi: 10.1002/ijc.22405. Int J Cancer. 2007. PMID: 17230511 Free article.

6

Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.

Karam JA, Shariat SF, Huang HY, Pong RC, Ashfaq R, Shapiro E, Lotan Y, Sagalowsky AI, Wu XR, Hsieh JT. Karam JA, et al. Among authors: hsieh jt. Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4400-6. doi: 10.1158/1078-0432.CCR-07-0287. Clin Cancer Res. 2007. PMID: 17671122

7

Genetic and biologic evidence that implicates a gene in aggressive prostate cancer.

Hsieh JT, Karam JA, Min W. Hsieh JT, et al. J Natl Cancer Inst. 2007 Dec 19;99(24):1823-4. doi: 10.1093/jnci/djm263. Epub 2007 Dec 11. J Natl Cancer Inst. 2007. PMID: 18073373 No abstract available.

8

Effect of trans-2,3-dimethoxycinnamoyl azide on enhancing antitumor activity of romidepsin on human bladder cancer.

Fan J, Stanfield J, Guo Y, Karam JA, Frenkel E, Sun X, Hsieh JT. Fan J, et al. Among authors: hsieh jt. Clin Cancer Res. 2008 Feb 15;14(4):1200-7. doi: 10.1158/1078-0432.CCR-07-1656. Clin Cancer Res. 2008. PMID: 18281555

9

Genomics: a preview of genomic medicine.

Karam JA, Shariat SF, Hsieh JT, Knowles MA. Karam JA, et al. Among authors: hsieh jt. BJU Int. 2008 Nov;102(9 Pt B):1221-7. doi: 10.1111/j.1464-410X.2008.07963.x. BJU Int. 2008. PMID: 19035885 No abstract available.

10

Conditionally replicating adenovirus therapy utilizing bone sialoprotein promoter (Ad-BSP-E1a) in an in vivo study of treating androgen-independent intraosseous prostate cancer.

Li Y, Kacka M, Thompson M, Hsieh JT, Koeneman KS. Li Y, et al. Among authors: hsieh jt. Urol Oncol. 2011 Nov-Dec;29(6):624-33. doi: 10.1016/j.urolonc.2009.08.012. Epub 2009 Dec 6. Urol Oncol. 2011. PMID: 19963408

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

408 results

Search Page